243 related articles for article (PubMed ID: 32960928)
1. The use of 4-Hexylresorcinol as antibiotic adjuvant.
Nikolaev YA; Tutel'yan AV; Loiko NG; Buck J; Sidorenko SV; Lazareva I; Gostev V; Manzen'yuk OY; Shemyakin IG; Abramovich RA; Huwyler J; El'-Registan GI
PLoS One; 2020; 15(9):e0239147. PubMed ID: 32960928
[TBL] [Abstract][Full Text] [Related]
2. Effect of 4-Hexylresorcinol on the Efficiency of Antibiotic Treatment of Experimental Sepsis Caused by Antibiotic-Resistant Klebsiella pneumoniae Strain in Mice.
Shemyakin IG; Manzenyuk OY; El'-Registan GI; Firstova VV; Kombarova TI; Gneusheva TY; Kyazimov EI; Nikolaev YA
Bull Exp Biol Med; 2021 Aug; 171(4):458-460. PubMed ID: 34542762
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
4. Gallium Nitrate Enhances Antimicrobial Activity of Colistin against Klebsiella pneumoniae by Inducing Reactive Oxygen Species Accumulation.
Guo M; Tian P; Li Q; Meng B; Ding Y; Liu Y; Li Y; Yu L; Li J
Microbiol Spectr; 2023 Aug; 11(4):e0033423. PubMed ID: 37272820
[TBL] [Abstract][Full Text] [Related]
5. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
[TBL] [Abstract][Full Text] [Related]
7. Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria.
Mahdavi M; Findlay BL
Bioorg Med Chem; 2024 Jan; 97():117541. PubMed ID: 38096681
[TBL] [Abstract][Full Text] [Related]
8. The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo.
Cebrián R; Xu C; Xia Y; Wu W; Kuipers OP
Int J Antimicrob Agents; 2021 Nov; 58(5):106434. PubMed ID: 34525402
[TBL] [Abstract][Full Text] [Related]
9. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance.
Liu L; Yu J; Shen X; Cao X; Zhan Q; Guo Y; Yu F
BMC Microbiol; 2020 Oct; 20(1):306. PubMed ID: 33045992
[TBL] [Abstract][Full Text] [Related]
12. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in
Cusini A; Herren D; Bütikofer L; Plüss-Suard C; Kronenberg A; Marschall J
Antimicrob Resist Infect Control; 2018; 7():89. PubMed ID: 30069305
[TBL] [Abstract][Full Text] [Related]
13. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
Lepak AJ; Andes DR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial effects of Apis mellifera and stingless bees honeys on susceptible and resistant strains of Escherichia coli, Staphylococcus aureus and Klebsiella pneumoniae in Gondar, Northwest Ethiopia.
Ewnetu Y; Lemma W; Birhane N
BMC Complement Altern Med; 2013 Oct; 13():269. PubMed ID: 24138782
[TBL] [Abstract][Full Text] [Related]
16. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae.
Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X
J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540
[TBL] [Abstract][Full Text] [Related]
17. Does inappropriate initial antibiotic therapy affect in-hospital mortality of patients in the emergency department with
Chen FC; Ho YN; Cheng HH; Wu CH; Change MW; Su CM
Int J Immunopathol Pharmacol; 2020; 34():2058738420942375. PubMed ID: 32698638
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the diagnosis and treatment strategy of polymyxin resistant
Chen YX; Xu YP; Zhu YG; Qu JM
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):813-818. PubMed ID: 37536993
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N
J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
[TBL] [Abstract][Full Text] [Related]
20. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
Borjan J; Meyer KA; Shields RK; Wenzler E
Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
